Home Newsfeeds Oppenheimer Downgrades Aurinia Pharmaceuticals to Perform

Oppenheimer Downgrades Aurinia Pharmaceuticals to Perform

Oppenheimer analyst Justin Kim downgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Outperform to Perform.

byBenzinga Newsdesk

November 4, 2022

1 minute read

Oppenheimer analyst Justin Kim downgrades Aurinia Pharmaceuticals (NASDAQ:AUPH) from Outperform to Perform.

$1000 Invested In Wheaton Precious Metals 5 Years Ago Would Be Worth This Much Today

By Benzinga Insights

August 29, 11:30 AM

Wheaton Precious Metals (NYSE:WPM) has outperformed the market over the past 5 years by 12.59% on an annualized…

WPM

Analyst Ratings

Expert Ratings for Crown Holdings

By Benzinga Insights

July 26, 8:00 AM

Within the last quarter, Crown Holdings (NYSE:CCK) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

CCK

Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher

By Lisa Levin

August 14, 2:52 PM

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The S&P 500, also rose, gaining, 0.28% to 4,476.67.

AMC

M&A
News

InterPrivate III Financial Partners Inc. Announces Extension of Deadline to Complete Initial Business Combination To June 9, 2023

By Happy Mohamed

May 4, 5:09 PM

InterPrivate III Financial Partners Inc. (NYSE:IPVF, IPVF, IPVF WS)))) (the "Company"), announced today that its board of directors (the "Board") has decided to extend the date by which the

IPVF

Oppenheimer Downgrades Aurinia Pharmaceuticals to Perform

Related Posts

$1000 Invested In Wheaton Precious Metals 5 Years Ago Would Be Worth This Much Today

Expert Ratings for Crown Holdings

Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher

InterPrivate III Financial Partners Inc. Announces Extension of Deadline to Complete Initial Business Combination To June 9, 2023